Company InformationCapsida is based in Newbury Park, California, USA. The number of employees in Capsida is unknown. Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic cns and non-cns disorders.
Here is how Capsida describes itself: "We are a biotechnology company creating a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications."
Funding & investorsCapsida has received 3 rounds of venture funding. The total funding amount is around $230M. Last venture funding round was $90M, announced on April, 2021.
- Versant Ventures (Venture capital)
- Westlake Village BioPartners (Incubator)
- AbbVie (Corporate venture capital)
Similar Companies [beta]
Active Venture Investors